A Zero-Voltage-Writing Artificial Nervous System Based on Biosensor Integrated on Ferroelectric Tunnel Junction

© 2024 Wiley‐VCH GmbH.

Bibliographische Detailangaben
Veröffentlicht in:Advanced materials (Deerfield Beach, Fla.). - 1998. - 36(2024), 32 vom: 18. Aug., Seite e2404026
1. Verfasser: Qin, Xiaokun (VerfasserIn)
Weitere Verfasser: Zhong, Bowen, Lv, Shuxian, Long, Xiao, Xu, Hao, Li, Linlin, Xu, Kaichen, Lou, Zheng, Luo, Qing, Wang, Lili
Format: Online-Aufsatz
Sprache:English
Veröffentlicht: 2024
Zugriff auf das übergeordnete Werk:Advanced materials (Deerfield Beach, Fla.)
Schlagworte:Journal Article artificial nervous system biocompatibility biosensor ferroelectric tunnel junction zero‐voltage‐writing Zirconium C6V6S92N3C Hafnium X71938L1DO mehr... hafnium oxide 3C4Z4KG52T Oxides
Beschreibung
Zusammenfassung:© 2024 Wiley‐VCH GmbH.
The artificial nervous system proves the great potential for the emulation of complex neural signal transduction. However, a more bionic system design for bio-signal transduction still lags behind that of physical signals, and relies on additional external sources. Here, this work presents a zero-voltage-writing artificial nervous system (ZANS) that integrates a bio-source-sensing device (BSSD) for ion-based sensing and power generation with a hafnium-zirconium oxide-ferroelectric tunnel junction (HZO-FTJ) for the continuously adjustable resistance state. The BSSD can use ion bio-source as both perception and energy source, and then output voltage signals varied with the change of ion concentrations to the HZO-FTJ, which completes the zero-voltage-writing neuromorphic bio-signal modulation. In view of in/ex vivo biocompatibility, this work shows the precise muscle control of a rabbit leg by integrating the ZANS with a flexible nerve stimulation electrode. The independence on external source enhances the application potential of ZANS in robotics and prosthetics
Beschreibung:Date Completed 08.08.2024
Date Revised 08.08.2024
published: Print-Electronic
Citation Status MEDLINE
ISSN:1521-4095
DOI:10.1002/adma.202404026